Distinguished Speakers

  • Ozan Alkan, Ph.D., Principal Scientist and Research Team Leader, Discovery, Merrimack Pharmaceuticals
  • Paul Andrews, Ph.D., Director of Operations, National Phenotypic Screening Centre, University of Dundee; Director and Owner, Stem Cell Solutions
  • Christophe Antczak, Ph.D., Lab Head, Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research
  • Chris Bakal, Ph.D., Team Leader, Dynamical Cell Systems, The Institute of Cancer Research
  • Anne G. Bang, Ph.D., Director, Cell Biology, Prebys Center, Sanford Burnham Prebys Medical Discovery Institute
  • Geoffrey A. Bartholomeusz, Ph.D., Associate Professor/Director, Target Identification and Validation Program, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center
  • Mark Bathe, Ph.D., Associate Professor of Biological Engineering, Massachusetts Institute of Technology
  • Anne E. Carpenter, Ph.D., Director, Imaging Platform, Broad Institute of Harvard and MIT
  • Neil Carragher, Ph.D., Professor, Drug Discovery, Institute of Genetics and Molecular Medicine, University of Edinburgh
  • Arijit Chakravarty, Ph.D., Director, Modeling and Simulation, Takeda Pharmaceuticals
  • Murat Cirit, Ph.D., Director, Systems Pharmacology, Massachusetts Institute of Technology
  • Pamela E. Constantinou, Ph.D., Assistant Research Professor, Department of BioSciences, Rice University
  • Edna Cukierman, Ph.D., Associate Professor, Cancer Biology Program, Fox Chase Cancer Center
  • Anthony M. Davies, Ph.D., Center Director: Translational Cell Imaging Queensland (TCIQ), Institute of Health Biomedical Innovation, Queensland University of Technology
  • Regis Doyonnas, Ph.D., Senior Principal Scientist, High-Content Screening and HTS-Flow Cytometry, Primary Pharmacology Group, Pfizer
  • Darren Finlay, Ph.D., Research Assistant Professor and Director of Tumor Analysis, Sanford Burnham Prebys Medical Discovery Institute
  • Xavier Gidrol, Ph.D., Lab Director, CEA/INSERM/UGA
  • Albert Gough, Ph.D., Associate Professor, Drug Discovery Institute, University of Pittsburgh
  • Lesley Mathews Griner, Ph.D., Investigator II, Lab Head, Molecular Pharmacology, Oncology Research, Novartis Institutes for BioMedical Research
  • Marc Hild, Ph.D., Senior Investigator, Novartis Institutes for BioMedical Research
  • Charles C. Hong, M.D., Ph.D., Associate Professor, Cardiovascular Medicine, Pharmacology, and Cell and Developmental Biology, Vanderbilt University School of Medicine
  • Jeremy L. Jenkins, Ph.D., Director, Developmental & Molecular Pathways, DMP Research Informatics, Novartis Institutes for BioMedical Research
  • Edward Kelly, Ph.D., Associate Professor, Pharmaceutics, University of Washington, Seattle
  • Doo Yeon Kim, Ph.D., Assistant Professor, Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Disease, Massachusetts General Hospital/ Harvard Medical School
  • Moo-Yeal Lee, Ph.D., Assistant Professor, Chemical & Biomedical Engineering, Cleveland State University
  • Sophie A. Lelièvre, DVM, Ph.D., LLMPH, Professor, Basic Medical Sciences, Scientific Director, 3D Cell Culture Core (3D3C) Facility, Purdue University Discovery Park
  • Geeta Mehta, Ph.D., Assistant Professor, Biomedical Engineering, University of Michigan
  • Mark Mercola, Ph.D., Professor, Department of Medicine and Cardiovascular Institute, Stanford University School of Medicine
  • Lisa Minor, Ph.D., President, In Vitro Strategies, LLC
  • Robert F. Murphy, Ph.D., Ray and Stephanie Lane Professor, Computational Biology and Professor, Biological Sciences, Biomedical Engineering, and Machine Learning, Head, Computational Biology, School of Computer Science, Carnegie Mellon University
  • Mary-Ann Mycek, Ph.D., Professor and Associate Chair for Translational Research, Department of Biomedical Engineering, College of Engineering & Medical School, University of Michigan
  • Matthias Nees, Ph.D., Coordinator, HCS Lab, Turku Science Park/Finland
  • Dana Nojima, Ph.D., Senior Scientist, Discovery Technology, Amgen
  • David Nolte, Ph.D., Professor, Physics, Purdue University; CTO, Animated Dynamics, Inc.
  • Stefan Prechtl, Ph.D., Senior Scientist, Bayer HealthCare AG
  • Sheila Ranganath, Ph.D., Director, R&D, Enumeral
  • Andrew J. Rennekamp, Ph.D., Research Fellow in Medicine, Massachusetts General Hospital, Harvard Medical School, and Broad Institute
  • Imran Rizvi, Ph.D., Instructor, Dermatology, Massachusetts General Hospital, Harvard Medical School
  • Christoph Sachse, Ph.D., Site Head Berlin, NMI TT Pharmaservices
  • Jeffrey Saucerman, Ph.D., Associate Professor, Biomedical Engineering, University of Virginia
  • Stuart Schreiber, Ph.D., Director, Center for the Science of Therapeutics, Broad Institute
  • Mark Schurdak, Ph.D., Director of Operations, University of Pittsburgh Drug Discovery Institute
  • Craig A. Simmons, Ph.D., Professor, Mechanical & Biomedical Engineering, University of Toronto
  • Shantanu Singh, Ph.D., Senior Group Leader, Broad Institute of Harvard and MIT
  • Bonnie Sloane, Ph.D., Distinguished Professor, Pharmacology, Wayne State University
  • Shay Soker, Ph.D., Professor, Regenerative Medicine, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine
  • David C. Swinney, Ph.D., CEO, Institute for Rare and Neglected Diseases Drug Discovery (iRND3)
  • Hossein Tavana, Ph.D., Associate Professor, Biomedical Engineering, University of Akron
  • Shuichi Takayama, Ph.D., Professor, Biomedical Engineering, University of Michigan
  • D. Lansing Taylor, Ph.D., Director, University of Pittsburgh Drug Discovery Institute & Allegheny Foundation Professor of Computational and Systems Biology, University of Pittsburgh
  • Fabien Vincent, Ph.D., Associate Research Fellow, Assay Development and Pharmacology, Hit Discovery and Lead Profiling, Pfizer Global Research & Development
  • Bridget Wagner, Ph.D., Director, Pancreatic Cell Biology and Metabolic Disease, Broad Institute